Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Receives Average Rating of “Hold” from Analysts

Shares of Carl Zeiss Meditec AG (OTCMKTS:CZMWY) have earned an average rating of “Hold” from the six analysts that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has issued a buy recommendation on the company.

A number of brokerages recently issued reports on CZMWY. Sanford C. Bernstein downgraded Carl Zeiss Meditec to a “market perform” rating in a research report on Monday, January 26th. The Goldman Sachs Group downgraded shares of Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a research note on Tuesday, January 20th.

Carl Zeiss Meditec Price Performance

OTCMKTS CZMWY opened at $27.40 on Tuesday. The business’s 50 day moving average price is $32.88 and its 200-day moving average price is $44.11. Carl Zeiss Meditec has a fifty-two week low of $26.65 and a fifty-two week high of $76.25.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.